Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Low vitamin D levels can significantly contribute to hair loss, especially in women aged 35-45. Correcting these levels early may help prevent and treat this condition.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Going to bed late may increase hormones and decrease muscle in women with PCOS.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

Blocking male hormones in baby rats improved memory and increased weight.

Spironolactone and metformin work similarly for PCOS symptoms, but more research is needed.

Ginsenoside Rf from Panax ginseng promotes hair growth and could be a natural alternative for treating hair loss.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Low vitamin D levels are linked to increased risk of male pattern baldness.

Androgen levels do not determine the type of PCOS symptoms in young females.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Early onset hair loss linked to genetics and androgen levels.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Lower zinc levels may predict less effective hair loss treatment.

Alopecia areata patients have lower vitamin D and slightly lower copper levels, so these should be checked.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.